Published in Int J Clin Exp Med on August 10, 2010
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
Patrolling monocytes control tumor metastasis to the lung. Science (2015) 1.10
FOXM1 promotes allergen-induced goblet cell metaplasia and pulmonary inflammation. Mol Cell Biol (2012) 1.04
Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia. Circulation (2013) 1.01
Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation. Oncogene (2011) 0.95
Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol (2013) 0.92
Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis. Mol Cancer (2013) 0.89
Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion. Am J Physiol Lung Cell Mol Physiol (2012) 0.81
Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension. Am J Pathol (2013) 0.81
RNA-Seq reveals a role for NFAT-signaling in human retinal microvascular endothelial cells treated with TNFα. PLoS One (2015) 0.78
The role of chemoattractant receptors in shaping the tumor microenvironment. Biomed Res Int (2014) 0.77
Cellular crosstalk between airway epithelial and endothelial cells regulates barrier functions during exposure to double-stranded RNA. Immun Inflamm Dis (2017) 0.75
Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. Mol Neurobiol (2016) 0.75
Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis. Sci Rep (2017) 0.75
Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol (2000) 14.74
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 8.97
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70
Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res (2006) 5.00
The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev (2003) 4.47
Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med (1998) 4.16
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol (1994) 3.83
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation (2008) 3.69
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood (2003) 3.51
Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J (2006) 3.42
Systemic inflammation in patients with COPD and pulmonary hypertension. Chest (2006) 3.30
CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med (2009) 3.07
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med (2003) 3.02
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91
Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol (2006) 2.70
CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood (2008) 2.52
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J (2008) 2.51
ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol Biol Cell (2009) 2.46
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med (1991) 2.45
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42
CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 2.15
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10
Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest (1994) 2.09
Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol (2000) 2.01
Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol (2008) 1.94
CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol (2007) 1.92
Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol (1999) 1.88
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood (2008) 1.87
Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol (2003) 1.80
Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol (2000) 1.79
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J (2006) 1.78
Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem (2003) 1.71
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy (2004) 1.58
Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis (1988) 1.58
Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol (2002) 1.53
CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms. J Immunol (2000) 1.53
Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2007) 1.52
Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol (2004) 1.51
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol (2001) 1.49
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res (2009) 1.44
Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest (2002) 1.43
The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol (2004) 1.41
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation (2003) 1.40
Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice. Am J Physiol Heart Circ Physiol (2008) 1.36
Hypoxia and chronic lung disease. J Mol Med (Berl) (2007) 1.36
Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res (1999) 1.33
Oxidative stress and accelerated vascular aging: implications for cigarette smoking. Front Biosci (Landmark Ed) (2009) 1.30
Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.29
Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J (2003) 1.28
CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol (2006) 1.27
Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxid Redox Signal (2008) 1.26
Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J Immunol (2005) 1.25
Pathophysiology and clinical effects of chronic hypoxia. Respir Care (2000) 1.24
Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. Am J Physiol Lung Cell Mol Physiol (2004) 1.24
Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity. J Immunol (2002) 1.23
Hypoxia, leukocytes, and the pulmonary circulation. J Appl Physiol (1985) (2005) 1.22
Mechanisms by which gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR). Novartis Found Symp (2002) 1.18
Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration. Immunobiology (2008) 1.18
Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J (1995) 1.17
Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). J Neuroimmunol (1997) 1.16
Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol (1994) 1.14
Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res (2007) 1.14
Lipid-bloated subretinal microglial cells are at the origin of drusen appearance in CX3CR1-deficient mice. Ophthalmic Res (2008) 1.14
Cigarette smoke condensate-induced adhesion molecule expression and transendothelial migration of monocytes. Am J Physiol (1996) 1.14
Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm Res (2002) 1.13
The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J Immunol (2006) 1.12
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J (2006) 1.11
Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation (2007) 1.11
Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol (1999) 1.10
Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood (2001) 1.09
The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. Br J Pharmacol (2008) 1.08
Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care (2004) 1.08
C and CX3C chemokines: cell sources and physiopathological implications. Crit Rev Immunol (2004) 1.07
CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD103- dendritic cells with distinct functional properties. J Immunol (2008) 1.07
Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A (1994) 1.06
CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema. Am J Pathol (2008) 1.06
Pathogenesis of COPD. Part III. Inflammation in COPD. Int J Tuberc Lung Dis (2008) 1.05
CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol (2006) 1.04
Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta (2000) 1.02
Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. Ann Rheum Dis (2005) 1.01
Clinical perspective of hypoxia-mediated pulmonary hypertension. Antioxid Redox Signal (2007) 0.98
Update in pulmonary arterial hypertension 2007. Am J Respir Crit Care Med (2008) 0.98
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci (2006) 0.98
Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum (2007) 0.97
The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells. Cancer Lett (2008) 0.96
Tackling COPD: a multicomponent disease driven by inflammation. MedGenMed (2006) 0.95
Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis (2007) 0.95
Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem Biophys Res Commun (2007) 0.95
Endothelial cells exposed to anoxia/reoxygenation are hyperadhesive to T-lymphocytes: kinetics and molecular mechanisms. Microcirculation (2000) 0.95
Chemokines, innate and adaptive immunity, and respiratory disease. Eur Respir J (2002) 0.95
Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation? Prim Care Respir J (2008) 0.95
Chemokines and their receptors in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med (2003) 0.94
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators. Thromb Res (2007) 0.94
Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients. COPD (2009) 0.93
Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J Neuroimmunol (1997) 0.93
Fractalkine induces chemotaxis and actin polymerization in human dendritic cells. Inflamm Res (2001) 0.92
Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc Am Thorac Soc (2008) 0.92
Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. Am J Respir Cell Mol Biol (2001) 0.92
A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol (2005) 4.95
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum (2009) 2.14
Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Am J Respir Crit Care Med (2013) 1.71
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.64
A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci (2009) 1.33
Laparoscopic management of perforated Meckel's diverticulum in adults. Int J Med Sci (2012) 1.26
Endothelial alpha-1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro. COPD (2008) 1.25
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res (2005) 1.23
Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus. Hum Genomics Proteomics (2009) 1.22
Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am J Physiol Cell Physiol (2004) 1.10
Autoinhibitory domain fragment of endothelial NOS enhances pulmonary artery vasorelaxation by the NO-cGMP pathway. Am J Physiol Lung Cell Mol Physiol (2004) 1.00
Hypoxic upregulation of arginase II in human lung endothelial cells. Am J Physiol Cell Physiol (2010) 0.97
Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells. Mech Ageing Dev (2003) 0.94
Reception thresholds for sentences in quiet and noise for monolingual English and bilingual Mandarin-English listeners. J Am Acad Audiol (2010) 0.92
Peptides modified by myristoylation activate eNOS in endothelial cells through Akt phosphorylation. Br J Pharmacol (2006) 0.92
Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol (2002) 0.90
Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells. Exp Lung Res (2009) 0.90
The effect of emodin on VEGF receptors in human colon cancer cells. Cancer Biother Radiopharm (2008) 0.89
A cellular model to mimic exhaled cigarette smokeinduced lung microvascular endothelial cell injury and death. Int J Clin Exp Med (2010) 0.88
Electrophysiological properties and subunit composition of GABAA receptors in patients with gelastic seizures and hypothalamic hamartoma. J Neurophysiol (2007) 0.88
Peptide-stimulation enhances compartmentalization and the catalytic activity of lung endothelial NOS. Cell Physiol Biochem (2009) 0.85
Transcutaneous vagus nerve stimulation for refractory epilepsy: a randomized controlled trial. Clin Sci (Lond) (2014) 0.84
Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses (2010) 0.84
Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo. Anticancer Agents Med Chem (2013) 0.83
Enhanced apoptosis in prolonged cultures of senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev (2002) 0.83
NO upregulation of a cyclic nucleotide-gated channel contributes to calcium elevation in endothelial cells. Am J Physiol Cell Physiol (2002) 0.83
Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol Cell Biochem (2003) 0.83
Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion. Am J Physiol Lung Cell Mol Physiol (2012) 0.81
Involvement of calpain-calpastatin in cigarette smoke-induced inhibition of lung endothelial nitric oxide synthase. Am J Respir Cell Mol Biol (2005) 0.81
Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study. PLoS One (2013) 0.81
Nitric oxide upregulation of caspase-8 mRNA expression in lung endothelial cells: role of JAK2/STAT-1 signaling. Mol Cell Biochem (2007) 0.80
Enhanced phosphorylation of caveolar PKC-α limits peptide internalization in lung endothelial cells. Mol Cell Biochem (2011) 0.80
Stuttering inhibition via visual feedback at normal and fast speech rates. Int J Lang Commun Disord (2011) 0.80
Hypoxic upregulation of preproendothelin-1 gene expression is associated with protein tyrosine kinase-PI3K signaling in cultured lung vascular endothelial cells. Int J Clin Exp Med (2009) 0.79
Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity. Peptides (2012) 0.79
Down-regulation of mitochondrial cytochrome c oxidase in senescent porcine pulmonary artery endothelial cells. Mech Ageing Dev (2002) 0.78
Priming donor lungs with thioredoxin-1 attenuates acute allograft injury in a rat model of lung transplantation. J Heart Lung Transplant (2008) 0.78
Sodium-phosphate symport by Aplysia californica gut. Zoolog Sci (2002) 0.78
Electrogenic proton-regulated oxalate/chloride exchange by lobster hepatopancreatic brush-border membrane vesicles. J Exp Biol (2004) 0.78
Endothelial arginase II responds to pharmacological inhibition by elevation in protein level. Mol Cell Biochem (2010) 0.77
Thyroid hormone-induced sulfate absorption in Aplysia californica gut is mediated by protein synthesis. Can J Physiol Pharmacol (2003) 0.77
Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells. Mol Cell Biochem (2005) 0.77
Existence and nature of the chloride pump. Biochim Biophys Acta (2003) 0.76
Plasma adiponectin: a possible link between fat metabolism and pancreatic cancer risk. J Natl Cancer Inst (2012) 0.75
Chloride ATPase pumps in nature: do they exist? Biol Rev Camb Philos Soc (2003) 0.75
Chloride-ATPase dephosphorylation in Aplysia gut. J Exp Zool (2002) 0.75
Thyroid-hormone-induced phosphate absorption in Aplysia californica gut is mediated through protein synthesis. Can J Physiol Pharmacol (2002) 0.75
Phosphate absorption by Aplysia californica gut: thyroid hormone stimulation. Can J Physiol Pharmacol (2002) 0.75
A novel method to decompose two potent greenhouse gases: photoreduction of SF6 and SF5CF3 in the presence of propene. J Hazard Mater (2007) 0.75
Nitric oxide-modulated marker gene expression of signal transduction pathways in lung endothelial cells. Nitric Oxide (2004) 0.75
Energetics of potassium ion transport in Aplysia gut. Zoolog Sci (2002) 0.75
Phosphate absorption in Aplysia californica gut: glucocorticoid inhibition. Can J Physiol Pharmacol (2003) 0.75